The anti‐inflammatory effects of Glycyrrhiza uralensis licorice extract

Han Jin Cho,Soon Sung Lim,Jong‐Sang Kim,Jung Han Yoon Park
DOI: https://doi.org/10.1096/fasebj.23.1_supplement.910.5
2009-04-01
The FASEB Journal
Abstract:Glycyrrhiza uralensis has long been used throughout the world as a sweetener and in folk medicine because of its antioxidative, anti‐inflammatory, antibacterial, antiangiogenic properties. Licorice contains various bioactive compounds, including glycyrrhizin, which is known to induce hypertension. We assessed the effect of the hexane/ethanol (90:10) extract of licorice (HEL) lacking glycyrrhizin on inflammatory responses in lipopolysaccharide (LPS)‐treated Raw264.7 murine macrophages. HEL (0 ‐ 2 μg/mL) decreased nitric oxide release, which was accompanied by decreases in the protein expression and transcriptional activity of iNOS. HEL decreased prostaglandin E 2 release via inhibition of phospholipase A 2 expression. HEL decreased LPS‐induced increases in the protein and mRNA levels of tumor necrosis factor‐α, IL‐6, and IL‐1β. HEL prevented LPS‐induced degradation of inhibitor of κBα, translocation of p65 to the nucleus, and NF‐κB DNA binding activities. HEL inhibited LPS‐induced phosphorylation of SAPK/JNK and c‐Jun, and LPS‐induced AP‐1 DNA binding activity. In skin inflammation model, HEL suppressed TPA‐induced swelling of skin. These results suggest that HEL exerts anti‐inflammatory effects via inhibition of NF‐κB and AP‐1 signaling.
What problem does this paper attempt to address?